11 авг. 2020 г. · This morning artificial intelligence-based drug discovery platform Atomwise scored a whopping $123 million in Series B funding led by B ...

11 авг. 2020 г. · The funding round includes returning investors DCVC, BV, Tencent, Y Combinator, Dolby Ventures, AME Cloud Ventures, as well as new backing from ...

11 авг. 2020 г. · Atomwise, which is using artificial intelligence for small molecule drug discovery, received a cash infusion of $123 million in an oversubscribed Series B ...

14 авг. 2020 г. · Atomwise's series B round brings its funding total up to nearly $175 million, with the latest financing led by B Capital Group and Sanabil ...

Atomwise announced on Tuesday that it closed a $123 million Series B funding round. That brings its total funding to date to $175 million.

20 авг. 2020 г. · Atomwise recently announced a Series B round of financing that will power the company on its journey to change the way drug discovery is done.

12 авг. 2020 г. · Atomwise, which operates an AI-based drug discovery platform, has raised $163 million CAD in what it called an oversubscribed Series B ...

12 авг. 2020 г. · Atomwise Inc. raised $123 million at the close of its oversubscribed series B funding round. The financing was led by B Capital Group Management ...

11 сент. 2020 г. · Atomwise which operates an artificial intelligence (AI)-based drug discovery platform, has raised $163 million CAD ($123 million USD) in ...

11 авг. 2020 г. · AtomNet uses structural information to predict binding between molecular targets and small molecules by processing millions of data points ...